Plain-English translation of NCT06934057 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Kidney Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a combination of two medications called and for older adults (age 70+) who have advanced kidney cancer. The study wants to learn whether this medication combination is effective and safe specifically for older patients, and how well they tolerate it. Researchers will carefully monitor participants' health and quality of life throughout the treatment.
Most kidney cancer studies focus on younger, healthier patients, so doctors don't always know how well these treatments work for older adults who may have other health conditions. This study was created to fill that gap and ensure older patients get the right information about whether this medication is right for them.
You likely qualify if…
You likely don't qualify if…
You would take the medication combination as your standard kidney cancer treatment. At the start, you'll have a special geriatric evaluation to assess your overall health and fitness for treatment. Throughout the study, you'll have regular visits with your cancer doctor, check-ins with a geriatrician (an older-adult specialist), and periodic phone calls to monitor how you're doing. Optional pharmacological support is available to help manage any side effects from the medication.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
France